Loudon Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-22,370
| Closed | -$567K | – | 103 |
|
|
2025
Q1 | $567K | Sell |
22,370
-7,000
| -24% | -$183K | 0.32% | 66 |
|
|
2024
Q4 | $779K | Sell |
29,370
-1,115
| -4% | -$30.2K | 0.44% | 53 |
|
|
2024
Q3 | $882K | Buy |
30,485
+17,800
| +140% | +$519K | 0.48% | 50 |
|
|
2024
Q2 | $355K | Buy |
+12,685
| New | +$349K | 0.21% | 78 |
|
|
2024
Q1 | – | Sell |
-9,210
| Closed | -$265K | – | 98 |
|
|
2023
Q4 | $265K | Sell |
9,210
-16,342
| -64% | -$494K | 0.16% | 87 |
|
|
2023
Q3 | $848K | Buy |
25,552
+275
| +1% | +$9.72K | 0.58% | 47 |
|
|
2023
Q2 | $927K | Hold |
25,277
| – | – | 0.61% | 48 |
|
|
2023
Q1 | $1.03M | Sell |
25,277
-200
| -0.8% | -$8.64K | 0.71% | 42 |
|
|
2022
Q4 | $1.31M | Hold |
25,477
| – | – | 0.94% | 39 |
|
|
2022
Q3 | $1.11M | Sell |
25,477
-750
| -3% | -$36.4K | 0.89% | 41 |
|
|
2022
Q2 | $1.38M | Sell |
26,227
-3,074
| -10% | -$157K | 1.03% | 31 |
|
|
2022
Q1 | $1.52M | Sell |
29,301
-550
| -2% | -$28.5K | 1% | 32 |
|
|
2021
Q4 | $1.76M | Hold |
29,851
| – | – | 1.13% | 31 |
|
|
2021
Q3 | $1.28M | Sell |
29,851
-2,516
| -8% | -$111K | 0.91% | 37 |
|
|
2021
Q2 | $1.27M | Sell |
32,367
-3,573
| -10% | -$139K | 0.86% | 37 |
|
|
2021
Q1 | $1.3M | Sell |
35,940
-25,525
| -42% | -$906K | 0.93% | 35 |
|
|
2020
Q4 | $2.26M | Sell |
61,465
-3,084
| -5% | -$113K | 1.77% | 23 |
|
|
2020
Q3 | $2.25M | Sell |
64,549
-1,749
| -3% | -$61.3K | 1.9% | 20 |
|
|
2020
Q2 | $2.06M | Sell |
66,298
-2,666
| -4% | -$90.6K | 1.78% | 20 |
|
|
2020
Q1 | $2.14M | Sell |
68,964
-3,847
| -5% | -$131K | 2.24% | 13 |
|
|
2019
Q4 | $2.71M | Hold |
72,811
| – | – | 2.11% | 13 |
|
|
2019
Q3 | $2.48M | Buy |
72,811
+2,482
| +4% | +$90.3K | 2.09% | 13 |
|
|
2019
Q2 | $2.89M | Hold |
70,329
| – | – | 2.45% | 13 |
|
|
2019
Q1 | $2.83M | Sell |
70,329
-230
| -0.3% | -$9.21K | 2.49% | 13 |
|
|
2018
Q4 | $2.92M | Sell |
70,559
-2,891
| -4% | -$120K | 2.77% | 11 |
|
|
2018
Q3 | $3.07M | Sell |
73,450
-4,290
| -6% | -$165K | 2.47% | 11 |
|
|
2018
Q2 | $2.68M | Buy |
77,740
+2,372
| +3% | +$81.1K | 2.14% | 13 |
|
|
2018
Q1 | $2.54M | Buy |
75,368
+1,897
| +3% | +$65.2K | 2.02% | 21 |
|
|
2017
Q4 | $2.52M | Buy |
73,471
+5,186
| +8% | +$177K | 1.91% | 22 |
|
|
2017
Q3 | $2.31M | Buy |
68,285
+15,382
| +29% | +$494K | 1.81% | 22 |
|
|
2017
Q2 | $1.69M | Buy |
52,903
+2,716
| +5% | +$85.7K | 1.28% | 29 |
|
|
2017
Q1 | $1.63M | Buy |
50,187
+40,285
| +407% | +$1.27M | 1.24% | 31 |
|
|
2016
Q4 | $305K | Buy |
9,902
+843
| +9% | +$25.7K | 0.24% | 67 |
|
|
2016
Q3 | $291K | Hold |
9,059
| – | – | 0.23% | 69 |
|
|
2016
Q2 | $303K | Buy |
+9,059
| New | +$289K | 0.24% | 68 |
|
Other funds holding PFE
Loudon Investment Management's PFE Position: Q2 2025 in Review
Loudon Investment Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 22,370 shares — an estimated $567K sold.
Loudon Investment Management first reported a position in PFE in Q2 2016 and held it in 35 quarters. The position peaked at $3.07M in Q3 2018. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Loudon Investment Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- Loudon Investment Management sold 22,370 Pfizer shares in Q2 2025, an estimated $567K.
- Loudon Investment Management first reported a position in Pfizer in Q2 2016 and held it in 35 quarters.
- Loudon Investment Management's Pfizer position peaked at $3.07M in Q3 2018.
- 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Loudon Investment Management's 13F filing for Q2 2025, filed 18 Jul 2025.